DoorDash, Inc. (DASH)

Theseus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3,911	4,019	2,656	1,977	2,504	4,345
Short-Term Investments	1,088	1,322	1,422	1,544	1,253	514
Cash & Short-Term Investments	4,999	5,341	4,078	3,521	3,757	4,859
Cash Growth	2.99%	30.97%	15.82%	-6.28%	-22.68%	535.16%
Accounts Receivable	840	732	533	400	349	291
Receivables	994	732	533	400	349	291
Prepaid Expenses	212	623	474	322	114	205
Restricted Cash	2,750	190	105	-	-	-
Other Current Assets	780	500	407	477	345	162
Total Current Assets	9,735	7,386	5,597	4,720	4,565	5,517
Property, Plant & Equipment	1,297	1,167	1,148	1,073	738	413
Long-Term Investments	725	835	583	521	1,059	-
Goodwill	3,529	2,315	2,432	2,370	316	316
Other Intangible Assets	890	510	659	765	61	74
Long-Term Deferred Charges	103	93	86	64	37	27
Other Long-Term Assets	671	539	334	276	33	6
Total Assets	16,950	12,845	10,839	9,789	6,809	6,353
Accounts Payable	345	321	216	157	161	80
Accrued Expenses	2,094	1,974	1,446	956	629	405
Short-Term Debt	-	-	-	-	-	364
Current Portion of Leases	78	68	68	55	26	15
Current Unearned Revenue	421	396	308	251	183	108
Other Current Liabilities	1,758	1,679	1,372	1,125	761	430
Total Current Liabilities	4,696	4,438	3,410	2,544	1,760	1,402
Long-Term Leases	452	468	454	456	373	238
Other Long-Term Liabilities	153	129	162	21	9	13
Total Liabilities	8,022	5,035	4,026	3,021	2,142	1,653
Additional Paid-In Capital	13,439	13,165	11,887	10,633	6,752	6,313
Retained Earnings	-4,777	-5,255	-5,154	-3,846	-2,081	-1,613
Comprehensive Income & Other	261	-107	73	-33	-4	-
Total Common Equity	8,923	7,803	6,806	6,754	4,667	4,700
Minority Interest	5	7	7	14	-	-
Shareholders' Equity	8,928	7,810	6,813	6,768	4,667	4,700
Total Liabilities & Equity	16,950	12,845	10,839	9,789	6,809	6,353
Total Debt	3,251	536	522	511	399	617
Net Cash (Debt)	2,473	5,640	4,139	3,407	4,008	4,242
Net Cash Growth	-50.43%	36.27%	21.49%	-14.99%	-5.52%	630.12%
Net Cash Per Share	5.56	13.11	10.53	9.17	11.90	67.99
Filing Date Shares Outstanding	427.19	420.1	404	392.08	348.41	321.46
Total Common Shares Outstanding	426.92	419.68	403.23	391.47	346.51	318.5
Working Capital	5,039	2,948	2,187	2,176	2,805	4,115
Book Value Per Share	20.90	18.59	16.88	17.25	13.47	14.76
Tangible Book Value	4,504	4,978	3,715	3,619	4,290	4,310
Tangible Book Value Per Share	10.55	11.86	9.21	9.24	12.38	13.53
Machinery	459	363	310	276	232	144
Construction In Progress	62	61	40	74	31	27
Leasehold Improvements	233	211	217	164	98	57

Updated May 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q